Efficacy and Tolerance of Telerobotic vs Standard Ultrasound Exam in Children

Sponsor
Centre Hospitalier Intercommunal Creteil (Other)
Overall Status
Completed
CT.gov ID
NCT04776174
Collaborator
ADECHOTECH (Other)
40
2
1
8.1
20
2.5

Study Details

Study Description

Brief Summary

In children with Covid-19, the diagnosis of Kawasaki Disease (KD) and pneumonia should be made very quickly. However, the regional hospitals surrounding Paris don't have the required expertise. The use of MELODY allows the paediatric team to quickly carry out the necessary examinations while avoiding the movement of patients and the risk of contamination.

The MELODY remote system developed by the company AdEchoTech is a CE marking telemedicine technique, allowing an expert to perform an ultrasound scan on a distant patient (several hundred/thousands of kms). The Melody system makes it possible to optimize ultrasound expertise resources wherever they are located (all specialties combined) The feasibility of the clinical use of telerobotic sonography has been demonstrated in adults for abdominal, cardiac and prenatal exam. Thus, the aim of this study is to assess the feasibility of this system in children.

Condition or Disease Intervention/Treatment Phase
  • Device: Ultrasound using the telerobotic Melody system
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Children will be initially scanned with a telerobotic ultrasound system. Within 3 hours after the telerobotic examination, patients will be scanned by a different sonographer with similar experience and qualifications using the conventional ultrasound, who will be blinded to the findings of the telerobotic examination.Children will be initially scanned with a telerobotic ultrasound system. Within 3 hours after the telerobotic examination, patients will be scanned by a different sonographer with similar experience and qualifications using the conventional ultrasound, who will be blinded to the findings of the telerobotic examination.
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Crossover Comparison of the Efficacy and Tolerance of Telerobotic vs Standard Ultrasound Exam in Children
Actual Study Start Date :
Mar 1, 2021
Actual Primary Completion Date :
Nov 3, 2021
Actual Study Completion Date :
Nov 3, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: standard and telerobotic ultrasound

Included patients will have both ultrasound examination: standard ultraosound (abdominal, cardiac or pulmonary depending on the prescription and telerobotic ultrasound

Device: Ultrasound using the telerobotic Melody system
The children will first have a telerobotic ultrasound abdominal, pulmonary or cardiac followed by a classical ultrasound.

Outcome Measures

Primary Outcome Measures

  1. Number of normal and abnormal standard and telerobotic ultrasound examinations [1 day]

    Number of normal and abnormal examination conclusion for telerobotic and conventional ultrasound examinations

Secondary Outcome Measures

  1. Age of participants [At baseline]

    Age of patients with telerobotic ultrasound

  2. Number of anomalies found [Up to 4 hours]

    Conventional and telerobotic ultrasound examinations results

  3. Parent satisfaction [Up to 4 hours]

    Parent satisfaction questioner for the telerobotic examination using a 5-point Liekert scale from 1: "strongly disagree" to 5: "strongly agree"

  4. Medical assistant satisfaction [Up to 4 hours]

    Medical assistant satisfaction questioner for the telerobotic examination using a 5-point Liekert scale from 1: "strongly disagree" to 5: "strongly agree"

  5. Sonographer satisfaction [Up to 4 hours]

    Sonographer satisfaction questioner for the telerobotic examination using a 5-point Liekert scale from 1: "strongly disagree" to 5: "strongly agree"

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient from 1 year to 10 years

  • Patient requiring an ultrasound exam (thoracic, abdominal or cardiac)

  • French social security affiliation

Exclusion Criteria:
  • Obesity defined by a BMI greater than 30

  • Open wound making it impossible to carry out an ultrasound scan

  • Algetic patient

  • Instability of vital functions

  • Impossible to remain in a seated position

  • Refusal to participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHI Créteil Créteil France 94000
2 CHI Villeneuve-Saint-Georges Villeneuve-Saint-Georges France

Sponsors and Collaborators

  • Centre Hospitalier Intercommunal Creteil
  • ADECHOTECH

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Intercommunal Creteil
ClinicalTrials.gov Identifier:
NCT04776174
Other Study ID Numbers:
  • CHILDMELODY
First Posted:
Mar 1, 2021
Last Update Posted:
Nov 22, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Nov 22, 2021